Does statin therapy lower risk for diagnosis with prostate cancer?

The question of whether regular use of statin therapy (with a drug like simvastatin or atorvastatin, for example) can actually lower risk for a diagnosis of prostate cancer is still unanswered as of today. … READ MORE …

Do the new data from the PCPT “change the game” when it comes to PSA screening?

So, with the new, 15-year survival data from the Prostate Cancer Prevention Trial (PCPT) published earlier this week (as discussed in a prior post), a key question for many is “Do these data significantly change the rationale for or against widespread screening for risk of prostate cancer?” … READ MORE …

Overall survival among participants in the Prostate Cancer Prevention Trial

The Prostate Cancer Prevention Trial (PCPT) showed that treatment with finasteride (a 5α-reductase inhibitor) could lower the number of prostate cancers diagnosed in the U.S. each year by about 25 percent. … READ MORE …

Comparative value of two prostate cancer risk calculators in Canadian patients

A newly published study has suggested that the risk calculator based on data from the European Randomized Study of Screening for Prostate Cancer (ERSPC-RC) may be a better predictor of risk for prostate cancer in Canadians that the risk calculator based on the US-based Prostate Cancer Prevention Trial (PCPT-RC). … READ MORE …

Prostate cancer prevention and screening: an ASCO update

Your editor was unable to attend the session on prostate cancer prevention and screening at the recent annual meeting of the American Society for Clinical Oncology (ASCO) because he is still working on how to be in two places at once. … READ MORE …

ASCO highlights three advances in prostate cancer in 2008

Each year the American Society for Clinical Oncology (ASCO) highlights the major advances made in the prevention and management of cancer (click here for the full text). Three advances made the list for prostate cancer in 2008 … but almost no one is acting on one of the most important of these! … READ MORE …

Prostate cancer news update: Friday, July 25

This morning’s news update includes data on:

  • The value of PSA testing in men who have already had a first, negative prostate biopsy
  • The potential of “partial cryoablation” as second line treatment for men who have disease recurrence following radiotherapy … MORE …